Literature DB >> 17689990

Significance of eIF4E expression in skin squamous cell carcinoma.

Z Salehi1, F Mashayekhi, F Shahosseini.   

Abstract

Cutaneous squamous cell carcinoma (SCC) is a malignant tumour of keratinising epidermal cells. This type of skin cancer is the second leading cause of death after melanoma, and it is the second most common type of non-melanoma skin cancer after basal cell carcinoma. The cellular and molecular events involved in the progression of skin cancers are largely unknown. Increased protein synthesis is necessary for the transition of cells from quiescence to proliferation. Translational control is critical for the proper regulation of the cell cycle, tissue induction and growth. Eukaryotic initiation factor eIF4E, an important regulator of translation, plays critical roles in neo-plastic transformation and cancer progression. We investigated eIF4E expression in 49 skin samples (six normal tissues, eight Bowen diseases, seven stage I, 10 stage II, 13 stage III and five stage IV SCCs). Results obtained demonstrated that all SCC samples, evaluated by SDS-PAGE, Western blotting and cap-affinity chromatography using m7GTP-sepharose, presented eIF4E expression (13.6+/-1.2), whereas, starting from stage 0 (4.1+/-0.9) to stage I (7.4+/-1.4), stage II (12.1+/-2.4), stage III (18.1+/-3.0) and stage IV (26.2+/-3.8) SCCs, a constant and significant increase of protein over expression (P<0.001) was observed. A high expression of eIF4E is correlated with advanced stages. The results presented in this study demonstrate a possible role of eIF4E in SCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17689990     DOI: 10.1016/j.cellbi.2007.06.006

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  14 in total

1.  Translation regulation in skin cancer from a tRNA point of view.

Authors:  Katerina Grafanaki; Dimitrios Anastasakis; George Kyriakopoulos; Ilias Skeparnias; Sophia Georgiou; Constantinos Stathopoulos
Journal:  Epigenomics       Date:  2018-12-19       Impact factor: 4.778

2.  Evaluation of eIF4E expression in an osteosarcoma-specific tissue microarray.

Authors:  Tanasa S Osborne; Ling Ren; John H Healey; Lauren Q Shapiro; Alexander J Chou; Richard G Gorlick; Stephen M Hewitt; Chand Khanna
Journal:  J Pediatr Hematol Oncol       Date:  2011-10       Impact factor: 1.289

3.  Small-molecule inhibition of oncogenic eukaryotic protein translation in mesothelioma cells.

Authors:  Esther Z Chen; Blake A Jacobson; Manish R Patel; Aniekan M Okon; Shui Li; Kerry Xiong; Abhishek J Vaidya; Peter B Bitterman; Carston R Wagner; Robert A Kratzke
Journal:  Invest New Drugs       Date:  2014-04-09       Impact factor: 3.850

4.  Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer.

Authors:  Andrew C Hsieh; Davide Ruggero
Journal:  Clin Cancer Res       Date:  2010-08-11       Impact factor: 12.531

5.  Antisense oligonucleotide targeting eukaryotic translation initiation factor 4E reduces growth and enhances chemosensitivity of non-small-cell lung cancer cells.

Authors:  S C Thumma; B A Jacobson; M R Patel; B W Konicek; M J Franklin; J Jay-Dixon; A Sadiq; A De; J R Graff; R A Kratzke
Journal:  Cancer Gene Ther       Date:  2015-07-31       Impact factor: 5.987

6.  Cetuximab Immunoliposomes Enhance Delivery of 5-FU to Skin Squamous Carcinoma Cells.

Authors:  Raquel Petrilli; Josimar O Eloy; Renata F V Lopez; Robert J Lee
Journal:  Anticancer Agents Med Chem       Date:  2017       Impact factor: 2.505

7.  5'-Cap‒Dependent Translation as a Potent Therapeutic Target for Lethal Human Squamous Cell Carcinoma.

Authors:  Ritesh Kumar Srivastava; Jasim Khan; Aadithya Arumugam; Suhail Muzaffar; Purushotham Guroji; Marina S Gorbatyuk; Craig A Elmets; Andrzej T Slominski; M Shahid Mukhtar; Mohammad Athar
Journal:  J Invest Dermatol       Date:  2020-09-21       Impact factor: 8.551

8.  Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma.

Authors:  Subhasis Das; Kaushik Kumar Dey; Goutam Dey; Ipsita Pal; Abhijit Majumder; Sujata MaitiChoudhury; Subhas C kundu; Mahitosh Mandal
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

9.  Targeting eukaryotic translation in mesothelioma cells with an eIF4E-specific antisense oligonucleotide.

Authors:  Blake A Jacobson; Saritha C Thumma; Joseph Jay-Dixon; Manish R Patel; K Dubear Kroening; Marian G Kratzke; Ryan G Etchison; Bruce W Konicek; Jeremy R Graff; Robert A Kratzke
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

Review 10.  The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma.

Authors:  Sathyen A Prabhu; Omar Moussa; Wilson H Miller; Sonia V Del Rincón
Journal:  Int J Mol Sci       Date:  2020-06-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.